SEARCH

SEARCH BY CITATION

References

  • 1
    Adelaide, J., M. Chaffanet, A. Imbert, F. Allione, J. Geneix, C. Popovici, et al. 1998. Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosom. Cancer 22:186199.
  • 2
    Adnane, J., P. Gaudray, C. A. Dionne, G. Crumley, M. Jaye, J. Schlessinger, et al. 1991. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6:659663.
  • 3
    Gelsi-Boyer, V., B. Orsetti, N. Cervera, P. Finetti, F. Sircoulomb, C. Rouge, et al. 2005. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol. Cancer Res. 3:655667.
  • 4
    Theillet, C., J. Adelaide, G. Louason, F. Bonnet-Dorion, J. Jacquemier, J. Adnane, et al. 1993. FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosom. Cancer 7:219226.
  • 5
    Ugolini, F., J. Adelaide, E. Charafe-Jauffret, C. Nguyen, J. Jacquemier, B. Jordan, et al. 1999. Differential expression assay of chromosome arm 8p genes identifies frizzled-related (FRP1/FRZB) and fibroblast growth factor receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 18:19031910.
  • 6
    Yang, Z. Q., K. L. Streicher, M. E. Ray, J. Abrams, and S. P. Ethier. 2006. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 66:1163211643.
  • 7
    Chin, K., S. DeVries, J. Fridlyand, P. T. Spellman, R. Roydasgupta, W. L. Kuo, et al. 2006. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10:529541.
  • 8
    Letessier, A., F. Sircoulomb, C. Ginestier, N. Cervera, F. Monville, V. Gelsi-Boyer, et al. 2006. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer 6:245.
  • 9
    Prentice, L. M., A. Shadeo, V. S. Lestou, M. A. Miller, R. J. deLeeuw, N. Makretsov, et al. 2005. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene 24:72817289.
  • 10
    Adelaide, J., P. Finetti, I. Bekhouche, L. Repellini, J. Geneix, F. Sircoulomb, et al. 2007. Integrated profiling of basal and luminal breast cancers. Cancer Res. 67:1156511575.
  • 11
    Garcia, M. J., J. C. Pole, S. F. Chin, A. Teschendorff, A. Naderi, H. Ozdag, et al. 2005. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 24:52355245.
  • 12
    Haverty, P. M., J. Fridlyand, L. Li, G. Getz, R. Beroukhim, S. Lohr, et al. 2008. High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosom. Cancer 47:530542.
  • 13
    Kwek, S. S., R. Roy, H. Zhou, J. Climent, J. A. Martinez-Climent, J. Fridlyand, et al. 2009. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis. Oncogene 28:18921903.
  • 14
    Yang, Z. Q., G. Liu, A. Bollig-Fischer, C. N. Giroux, and S. P. Ethier. 2010. Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res. 70:84878497.
  • 15
    Zhang, J., X. Liu, A. Datta, K. Govindarajan, W. L. Tam, J. Han, et al. 2009. RCP is a human breast cancer-promoting gene with Ras-activating function. J. Clin. Invest. 119:21712183.
  • 16
    Holland, D. G., A. Burleigh, A. Git, M. A. Goldgraben, P. A. Perez-Mancera, S. F. Chin, et al. 2011. ZNF703 is a common luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol. Med. 3:167180.
  • 17
    Sircoulomb, F., N. Nicolas, A. Ferrari, P. Finetti, I. Bekhouche, E. Rousselet, et al. 2011. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. EMBO Mol. Med. 3:153166.
  • 18
    Curtis, C., S. P. Shah, S. F. Chin, G. Turashvili, O. M. Rueda, M. J. Dunning, et al. 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486:346352.
  • 19
    Slorach, E. M., J. Chou, and Z. Werb. 2011. Zepp o1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev. 25:471484.
  • 20
    Andrews, J. L., A. C. Kim, and J. R. Hens. 2012. The role and function of cadherins in the mammary gland. Breast Cancer Res. 14:203.
  • 21
    Perou, C. M., T. Sorlie, M. B. Eisen, M. van de Rijn, S. S. Jeffrey, C. A. Rees, et al. 2000. Molecular portraits of human breast tumours. Nature 406:747752.
  • 22
    Sorlie, T., C. M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98:1086910874.
  • 23
    Hu, Z., C. Fan, D. S. Oh, J. S. Marron, X. He, B. F. Qaqish, et al. 2006. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96.
  • 24
    Sorlie, T., R. Tibshirani, J. Parker, T. Hastie, J. S. Marron, A. Nobel, et al. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100:84188423.
  • 25
    Parker, J. S., M. Mullins, M. C. Cheang, S. Leung, D. Voduc, T. Vickery, et al. 2009. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27:11601167.
  • 26
    Loi, S., B. Haibe-Kains, C. Desmedt, F. Lallemand, A. M. Tutt, C. Gillet, et al. 2007. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J. Clin. Oncol. 25:12391246.
  • 27
    Cheang, M. C., S. K. Chia, D. Voduc, D. Gao, S. Leung, J. Snider, et al. 2009. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J. Natl. Cancer Inst. 101:736750.
  • 28
    Jonsson, G., J. Staaf, J. Vallon-Christersson, M. Ringner, K. Holm, C. Hegardt, et al. 2010. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res. 12:R42.
  • 29
    Jonsson, G., J. Staaf, J. Vallon-Christersson, M. Ringner, S. K. Gruvberger-Saal, L. H. Saal, et al. 2012. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer. Cancer Res. 72:40284036.
  • 30
    Venkatraman, E. S., and A. B. Olshen. 2007. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23:657663.
  • 31
    The R project for statistical computing. 2012 Available at http://www.r-project.org.
  • 32
    UCSC genome browser. Available at http://genome.ucsc.edu/.
  • 33
    Peduzzi, P., J. Concato, A. R. Feinstein, and T. R. Holford. 1995. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J. Clin. Epidemiol. 48:15031510.
  • 34
    Santarius, T., J. Shipley, D. Brewer, M. R. Stratton, and C. S. Cooper. 2010. A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 10:5964.
  • 35
    Tran, B., and P. L. Bedard. 2011. Luminal-B breast cancer and novel therapeutic targets. Breast Cancer Res. 13:221.
  • 36
    Robinson, J. T., H. Thorvaldsdóttir, W. Winckler, M. Guttman, E. S. Lander, G. Getz, et al. 2011. Integrative genomics viewer. Nat. Biotechnol. 29:2426.
  • 37
    Thorvaldsdóttir, H., J. T. Robinson, and J. P. Mesirov. 2013. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 14:178192.